Pharmatech is here to accelerate oncology products to market and into the hands of patients who need them most. Our therapeutically-aligned project teams provide a full range of clinical trial services from protocol design to FDA submission. Most importantly, we provide a superior level of quality and commitment to each study, including oversight provided by a dedicated member of our executive management team.
In OncologyExperience is Everything
Oncology clinical trials are inherently complex and require a thorough understanding of the hurdles associated with effectively implementing these programs. Each indication presents its own unique challenges from the operational, data, site, physician, and patient perspectives. Knowledge of the clinical and medical intricacies of the malignancies specifically targeted by your drug or biologic will greatly enhance trial execution. Pharmatech’s deep oncology expertise assures just that.
Early to Mid-Phase
- Make rapid, well-informed decisions regarding cohort enrollment and dose escalations
- Remain flexible to trial modifications, including seamless and adaptive designs
- Closely monitor the safety, laboratory, and data intricacies of treating critically ill subjects
- Streamline large amounts of data with full transparency of information via a fully integrated eClinical infrastructure
- Ensure enrollment goals are met through a global footprint
- Fully understand the potential impact on the subject through our medical and clinical staff that encompasses board-certified hematologists / oncologists, including our CSO with more than 20 years of research and industry experience
There are significant inefficiencies in the clinical trials process and Pharmatech solutions overcomes them to provide a significant cost savings for managing CRO and SMO projects. Our unique enrollment methodology provides not only a highly efficient enrollment strategy but also a cost effective solution. By eliminating non-enrolling sites and using previously screened patients for biomarker trials, Pharmatech has eradicated superfluous costs and streamlined the entire clinical trial process.
A direct focus on patients, is just one more thing that sets Pharmatech apart from other companies in the clinical trials industry. By ensuring that patients have easy and supported access to clinical trials, that are not only saving their lives but also the lives of those around them, Pharmatech is ensuring that future generations can benefit from the results that we find today.
Throughout studies we are fully dedicated to ensuring that your trial is run not only efficiently but as transparently as possible. Pharmatech views themselves as a partner to each sponsor and as a partner it is completely invested in a positive and successful outcome.
Our approach has shown a higher success rate than many of the traditional enrolling methods by 30 – 200% improvement. Contact us to learn how you can double your enrollment rates, mitigate risks, and eliminate non-accruing sites.